“showed a trend”

In NORT for long‐term memory assessment, only non‐transgenic female controls showed a trend in favor of spending more time with the new as compared to the old object ( p = 0.053, Figure S1 in Appendix S1 ). 3.2.

Within-group tests showed that participants in the WA-MBP-LS group significantly improved on JSS at posttest (B = 1.84, 95% CI = 0.19–3.49, d = 0.42, z = 2.19, p = 0.029), and they showed a trend very close to significance and of similar ES at follow-up (B = 1.94, 95% CI = −0.03–3.90, d = 0.48, z = 1.94, p = 0.053).

Capillary hyperemia (peak capillary density corrected for baseline capillary density) showed a trend toward a statistically significant association with mGFR ( β = 0.391; p = .053) in the covariate‐adjusted model.

A separate analysis of the CSS of patients whose primary tumors were examined showed a trend toward a worse survival outcome ( p = 0.053, Figure 5 D, bottom panel).

Although the mFI-5 showed a trend toward predicting PFS, this did not reach statistical significance (HR = 1.507; p = .053).

Age Subgroup: Patients under 60 years old showed a trend towards lower hypoxemia rates with the narrow-bore tube, with an OR of 0.42 [95% CI, 0.17–1.01], p = 0.053, which was not statistically significant.

Body weight was comparable in male mice, whereas female DKO mice showed a trend toward increased body weight ( P = 0.053) ( Supplemental Figure 9A ).

Simple slope analyses for APOE4 carrier showed a trend positive relationship for females (β (SE) = 0.16 (0.08), CI -0.002–0.32, p = 0.053), and a significantly negative association (β (SE) = -0.20 (0.10), CI -0.40 – -0.001, p = 0.049) for males (Fig. 4 B), between occupational attainment and episodic and relational memory.

3 a) also showed a trend toward a better neurological outcome when compared with tMCAo;Ctrl ( p = 0.0531, Fig. 3 g).

As concerns clinical features, no significant predictor of edema was identified; arterial hypertension showed a trend towards a reduced edema risk ( p = 0.0532, Fisher Exact Test).

Here also Lactobacillus showed a trend towards statistical significance (p = 0.0533), with a positive relationship. 8.

Corresponding with the slightly earlier and lengthened “siesta” period, Gad2-Cre:: Ube3a mFLOX/p+ mice showed a trend toward increased total sleep in the dark cycle ( Fig. 5 B ; genotype × time interaction: F (2,39) = 3.164, p = 0.0533).

High staining also showed a trend, albeit statistically insignificant, association with advanced tumors (regional extension + metastatic) ( P = 0.0534).

Primary disease showed a trend toward a superior response to GARD when compared with systemic disease (median survival, 10 years vs 11.5 years; P = .0535; supplemental Table 3 ; supplemental Figure 1 A).

Comparison of survival curves showed a trend ( p = 0.0537) of differing larval mortality between all APEC isolates ( Figure 6 ).

Moreover, Sema3F KO mice showed a trend to stay shorter time in the light chamber than WT controls (Fig. 3d , t 33 = 2.001, p = 0.0537).

Scn2a +/– , −37.36 ± 0.6 mV; t = 2.262, p = 0.0288; Figures 4D–F ), and AP width showed a trend toward broadening ( p = 0.0537), while other waveform parameters were largely comparable between genotypes.

However, rs73393881, an intron variant of ALDH1L2, showed a trend of significance (empirical p -value = 0.05379, OR = 0.4803) between the cases and the controls after permutation, while all 9 SNPs, after QC, in ALDH8A1 SNPs did not.

Octadecenoylcarnitine (C18:1) showed a trend toward reduction ( P = 0.0538, FDR = 0.099).

Although no significant differences were observed, the analysis showed a trend towards a greater improvement in LBP for the paracetamol 1000 mg/ibuprofen 300 mg group ( p = 0.0539) at visit 1.

Vglut2-cKO mice showed a trend of increased episode number of wakefulness ( p = 0.0539) and NREMS ( p = 0.0786) ( Figure 5 C), whereas the average episode duration of NREMS was shorter in Vglut2-cKO mice than in WT littermates ( Figure 5 D).

Interestingly, the involvement of difficult-to-treat areas did not appear as a significant predictor of treatment discontinuation in the multivariate analysis, except for genital psoriasis, which showed a trend toward a lower dropout risk ( P =0.0539).

In contrast to our findings, in a retrospective study of patients with activating EGFR mutations ( n = 123) who were treated with EGFR TKIs, OS showed a trend in favor of continuing versus discontinuing EGFR TKI treatment following RECIST PD (33.0 versus 21.2 months, respectively; p = 0.054) [ 25 ].

When compared with men with high SES, those with low SES had greater risk for ICU treatment ≥5 days (multivariate-adjusted OR 1.99; 95% CI 1.06–3.74; p = 0.036) and showed a trend for a low number of visits from next-of-kin (<0.5 visits per day) (OR 1.85; 95% CI 0.79–4.30; p = 0.054).

The FCC grid model was significant in the left EC (t(28) = 2.6, p = 0.008, one-sided), and showed a trend in the right EC (t(28) = 1.7, p = 0.054, one-sided) ( Fig. 7 B).